In August 2024, the American Society for Gastrointestinal Endoscopy (ASGE) and the American College of Gastroenterology (ACG) published an update on quality indicators for colonoscopy to ensure that the highest standards are met for performing colonoscopy.1That same month, the American Cancer Society ...
HER2Human epidermal growth factor receptor 2Genetic profilingPrecision oncologyObjectives:Human epidermal growth factor receptor 2(HER2)-targeted therapies have demonstrated potential benefits for metastatic colorectal cancer(mCRC)patients with HER2 amplification,but are not satisfactory in cases of HER2 mutant...
and therapy of disease, this guide covers new pharmaceutical developments, current screening protocols, and modern methods of disease management by specialists at renowned institutions such as the Royal Marsden Hospital, the Memorial Sloan Kettering Cancer Center, and the Vanderbilt-Ingram Cancer Center....
出处 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2024年第3期233-239,共7页 中国癌症研究(英文版) 基金 supported by the Provincial Key R&D Program of Zhejiang Province(No.2021C03125) National Natural Science Foundation of China(No.82373415 and No.82302489) Beijing Xisike Clinical Oncolo...
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC statistics based on incidence from population-based cancer registries and mortality from the National Center for Health Statistics. In...
and treatment of colorectal cancer and other Gastrointestinal Malignancies including pancreas, liver and esophageal cancer.Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators...
Acquired drug resistance is a major challenge for cancer therapy and is the leading cause of cancer mortality; however, the mechanisms of drug resistance are diverse and the strategy to specifically target drug-resistant cancer cells remains an unmet cli
GC Genome Corporation, a leading diagnostics company, announced that it will present the new clinical data of its AI-based liquid biopsy platform on colorectal cancer detection at the 2024 American Society of Clinical Oncology Annual Meeting in Chicago, May 31–June...
Challenges in Colorectal Cancer provides the most up-to-date information on the new and emerging treatments. The second edition looks at the total patient management of this condition and is aimed at the entire medical team caring for those with colorectal cancer. It also contains the latest ...
Managing Cancer Pain at the End of Life with Multiple Strong Opioids: A Population-Based Retrospective Cohort Study in Primary Care Background End-of-life cancer patients commonly receive more than one type of strong opioid. The three-step analgesic ladder framework of the World Health ... W ...